Journal Article

Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects

José F. Téllez-Zenteno, Rajat Dhar, Lizbeth Hernandez-Ronquillo and Samuel Wiebe

in Brain

Published on behalf of The Guarantors of Brain

Volume 130, issue 2, pages 334-345
Published in print February 2007 | ISSN: 0006-8950
Published online November 2006 | e-ISSN: 1460-2156 | DOI: http://dx.doi.org/10.1093/brain/awl316
Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects

Show Summary Details

Preview

Assessment of long-term outcomes is essential in brain surgery for epilepsy. Little information exists on long-term non-seizure outcomes after epilepsy surgery. We perform a systematic review and meta-analysis of the evidence on this topic. Our aim was to provide evidence-based estimates of antiepileptic drug, psychosocial, neuropsychological and mortality long-term outcomes following epilepsy surgery, and to identify sources of variation in published results. We searched Medline, Index Medicus, the Cochrane database, bibliographies of reviews, original articles, and book chapters, to identify articles published from 1991 to 2005, containing ≥20 patients of any age, undergoing resective or non-resective epilepsy surgery, and followed for a mean/median of ≥5 years. Two reviewers independently assessed study eligibility and extracted data, resolving disagreements through discussion. Standard meta-analytical techniques were used to pool data. Of the 159 potentially eligible articles reviewed in full-text, 35 (22%) fulfilled eligibility criteria; 6 (17%) were controlled studies; 15 (36%) explored antiepileptic drug outcome; 6 (17%) explored mortality; 11 (31%) reported psychosocial outcomes; and 7 (20%) explored neuropsychological outcomes. On an average, 14% [95% confidence interval (CI95) = 11–17] of the patients with temporal lobe surgery achieved long-term antiepileptic drug (AED) discontinuation, 50% (CI95 = 45–55) achieved monotherapy, and 33% remained on polytherapy (CI95 = 29–38). In analyses including all types of surgery, on average, 20% (CI95 = 18–23) achieved long-term AED discontinuation, while 41% (CI95 = 37–45) were on monotherapy and 31% (CI95 = 27–35) remained on polytherapy. Children achieved better AED outcomes than adults. Seizure freedom after surgery was associated with lower mortality, but inconsistent mortality outcomes precluded making strong inferences. Non-controlled studies consistently reported improved long-term psychosocial outcomes, but the effect was less clear in controlled studies. Intelligence was unchanged by surgery, but long-term memory outcomes were associated with seizure freedom and side of temporal lobe resection. Few long-term, controlled studies exist. Longer follow-up was associated with lower rates of AED discontinuation, reflecting lower seizure-free rates over time. Cognitive and psychosocial outcomes were similar to those of short-term studies, and the results were influenced by the presence of controls.

Keywords: antiepileptic drugs; controlled studies; epilepsy surgery; long-term outcome; mortality

Journal Article.  5741 words.  Illustrated.

Subjects: Neurology ; Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.